1,000
Participants
Start Date
October 15, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Heparin-binding protein
Evaluation of the specificity and sensitivity of HBP as diagnostic biomarker for VAP.
Interleukin-26
Evaluation of the specificity and sensitivity of IL-26 as diagnostic biomarker for VAP.
Microbiome
Evaluation of the specificity and sensitivity of the lung microbiome as prognostic biomarker for VAP.
Bacterial transcriptome
Evaluation of the specificity and sensitivity of the bacterial transcriptome as prognostic biomarker for treatment failure of VAP.
Proteome
Evaluation of the specificity and sensitivity of the proteome in mini-BAL as biomarker for VAP.
RECRUITING
Vestre Viken, Drammen
RECRUITING
Hospital de São Francisco Xavier, Lisbon
RECRUITING
Skåne University Hospital, Dept. of Infectious diseases, Lund
RECRUITING
Skåne university Hospital, ICU, Malmo
NOT_YET_RECRUITING
Karolinska University Hospital, ICU, Solna
Lund University
OTHER
Region Skane
OTHER